AstraZeneca PLC (ZEGA) — Cash Flow Quality Index
AstraZeneca PLC (ZEGA) has a Cash Flow Quality Index of 2.03x as of September 2025. Operating cash flow of €5.13 Billion exceeds net income of €2.53 Billion, indicating high earnings quality where cash backs reported profits. Explore ZEGA cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
AstraZeneca PLC Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for AstraZeneca PLC across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ZEGA cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for AstraZeneca PLC (2014–2024)
Year-by-year earnings quality comparison for AstraZeneca PLC. For live market cap and the full company financial profile, see AstraZeneca PLC (ZEGA) total market value.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.69x | €11.86 Billion | €7.04 Billion | ▼ -3.0% |
| 2023 | 1.74x | €10.36 Billion | €5.96 Billion | ▼ -41.7% |
| 2022 | 2.98x | €9.81 Billion | €3.29 Billion | ▼ -94.4% |
| 2021 | 53.24x | €5.96 Billion | €112.00 Million | ▲ +3445.7% |
| 2020 | 1.50x | €4.80 Billion | €3.20 Billion | ▼ -32.5% |
| 2019 | 2.22x | €2.97 Billion | €1.33 Billion | ▲ +83.1% |
| 2018 | 1.21x | €2.62 Billion | €2.15 Billion | ▲ +1.9% |
| 2017 | 1.19x | €3.58 Billion | €3.00 Billion | ▲ +0.6% |
| 2016 | 1.18x | €4.14 Billion | €3.50 Billion | ▲ +0.7% |
| 2015 | 1.18x | €3.32 Billion | €2.83 Billion | ▼ -79.4% |
| 2014 | 5.72x | €7.06 Billion | €1.23 Billion | — |